27.80MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-02The current institutional shareholding score of Rein Therapeutics Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 16.21%, representing a quarter-over-quarter decrease of 51.20%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.09% of shares outstanding, with 214.69% increase in holdings.
Institutional Shareholding
Shareholder Activity
Bios Equity Partners, LP.
University of Texas Investment Management Company
Sigma Planning Corporation
Geode Capital Management, L.L.C.
Texas Capital Bank Private Wealth Advisors